Gsk Share Discussion Threads

[mj19] 05/2/2024 12:22

Think long term if it drops just top up

[mister md] 05/2/2024 12:16

This is going up in a very 'non-FTSE-stock' kind of way !!

[montyhedge] 05/2/2024 09:49

DB raising target 1950p very good, because they are tough on price targets.

[igoe104] 05/2/2024 08:38

Everything comes down to momentum with shares.

[supermarky] 05/2/2024 08:10

Things definitely looking up here at the moment

[dplewis1] 05/2/2024 08:02

Deutsche Bank raises target price to 1950p from 1850p

[tradermichael] 02/2/2024 16:27

Cup and handle?

[supermarky] 02/2/2024 15:51

this seems like a breakout

[rikky72] 02/2/2024 15:44

Nice to see £16 broken

[tradermichael] 02/2/2024 10:28

It might take some more time as the profit-takers drop off and fresh buyers come in .... ;0)

[montyhedge] 02/2/2024 10:23

If they break 1600p hopefully thats support level and not resistance level.

[pcok] 01/2/2024 18:02

On the ADVFN chart looks to be the highest close since the demerger. In addition 2 people in the know buying shares. Hope it lasts...

[tuftymatt] 01/2/2024 10:23

Hopefully we can now push on to 1620+ in the short term.

Good luck all 👍🏻

[alibizzle] 01/2/2024 10:22

Yeah surely this means everyone has to get payed in settlements? So they admit liability but at that same time don't admit liability. WTF

[disc0dave46] 01/2/2024 09:54

Not exactly defending itself is it, paying out to anyone that sues. Opening the floodgates IMO.

[steeplejack] 01/2/2024 09:12

Oh well,only a few hours until Wall Street opens and we'll get a response!

[waldron] 01/2/2024 08:42

2024 Guidance

GSK expects 2024 sales to increase between 5 to 7 per cent and Adjusted Operating profit to increase between 7 to 10 per cent. Adjusted Earnings per share is expected to increase between 6 to 9 per cent. This guidance is provided at CER and excludes any contribution from COVID-19 related solutions.

The Group has made planning assumptions that we expect sales to increase between 5 to 7 per cent, with high single digit to low double-digit growth for Vaccines, low double-digit growth for Specialty Medicines and a mid-single-digit decline for General Medicines.

[laurence llewelyn binliner] 01/2/2024 07:13

RNS - 01.02.2024 - GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with David Browne, resolving the case he filed in California state court. This case was set to go to trial on 20 February 2024, and instead will now be dismissed. The settlement reflects the Company's desire to avoid the distraction related to protracted litigation in this case. GSK does not admit any liability in this settlement and will continue to vigorously defend itself based on the facts and the science in all other Zantac cases.

[cumnor] 31/1/2024 18:02

UK IIs should have been on this, this AM, after fall but all asleep as usual. Took WS-any wonder London dying as a market-no UK II support.

[zho] 31/1/2024 14:58

GSK's RSV vaccine success makes its shares look cheap

After years as a sector laggard, the company has decided to make a name for itself in immunisations

At this point, there’s no way to estimate the cost of resolving the [Zantac] saga, but with shares trading on just 10 times forward earnings for 2024, we’d argue GSK looks cheap for a company on the up. Buy.

[ianood] 31/1/2024 14:49

Yes, must say I'm eating humble pie!

[steeplejack] 31/1/2024 14:39

Nothing's changed over the decades.It requires the US market to determine the reaction to figures.The UK flounders without a Wall Street lead.

[pcok] 31/1/2024 14:26

Good results that point to a growing and increasingly profitable future. Not wishing to count chickens before hatching but could it be that the much maligned CEO has done a good job and managed to redirect this oil tanker into more rewarding waters. I for one think so. She took on a helluva big job and we seem to be seeing the hard work beginning to pay off. There ain't nothin like a Dame.

[rikky72] 31/1/2024 14:21

To be fair, things weren't too bad but then some woke up to Zantac and acted like GSK had put cyanide in all its marketed drugs :(